https://www.zacks.com/stock/news/2210892/foot-locker-fl-to-gain-from-lace-up-plan-market-adaptation?cid=CS-ZC-FT-analyst_blog|rank_focused-2210892
Jan 16, 2024 - Foot Locker (FL) strengthens its omnichannel presence and sneaker culture focus, banking on key brand partnerships and NBA collaboration.
zc:-365777839778038143
0
https://www.zacks.com/stock/news/2211642/will-ups-ups-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2211642
Jan 17, 2024 - UPS (UPS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:4837641891004671086
0
https://www.zacks.com/stock/news/2211682/u-s-bancorp-s-usb-q4-earnings-meet-estimates-costs-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2211682
Jan 17, 2024 - U.S. Bancorp's (USB) Q4 earnings gain from a rise in revenues and an improvement in credit quality. However, higher expenses and lower NII act as headwinds.
zc:1058287590981379825
0
https://www.zacks.com/stock/news/2211589/ulta-beauty-ulta-up-on-omni-channel-strength-skincare-sales?cid=CS-ZC-FT-analyst_blog|rank_focused-2211589
Jan 17, 2024 - Ulta Beauty (ULTA) continues to invest in enhancing guest experience in all touch points. A positive view of the beauty space is keeping the company well-positioned.
zc:6460722547951797640
0
https://www.zacks.com/stock/news/2211671/csx-gears-up-to-report-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2211671
Jan 17, 2024 - CSX's fourth-quarter 2023 revenues are expected to have been weighed down by segmental weakness.
zc:1749061661071760164
0
https://www.zacks.com/stock/news/2212369/cboe-global-cboe-up-53-in-a-year-time-to-add-to-portfolio?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2212369
Jan 18, 2024 - Cboe Global's (CBOE) strong market position, global reach, proprietary products' strength and solid capital position poise it well for growth.
zc:6764601889962095564
0
https://www.zacks.com/stock/news/2212826/3m-mmm-gears-up-to-post-q4-earnings-is-a-beat-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212826
Jan 19, 2024 - 3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results.
zc:-7049465733144145522
0
https://www.zacks.com/stock/news/2212927/mesoblast-meso-up-on-rare-pediatric-disease-tag-for-heart-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212927
Jan 19, 2024 - Mesoblast's (MESO) Revascor (rexlemestrocel-L) gets FDA's Rare Pediatric Disease designation for treating children with congenital heart disease. Shares rise in after-hours trading.
zc:6994723974281765028
0
https://www.zacks.com/stock/news/2213012/dave-buster-s-play-up-36-in-three-months-more-upside-left?cid=CS-ZC-FT-analyst_blog|rank_focused-2213012
Jan 19, 2024 - Dave & Buster's (PLAY) focuses on introducing more entertainment options, enhancing guest engagement and implementing a digital guest platform to drive growth.
zc:-242042731993055080
0
https://www.zacks.com/stock/news/2213586/xerox-xrx-gears-up-for-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213586
Jan 22, 2024 - Xerox's (XRX) fourth-quarter 2023 earnings and revenues are likely to decrease year over year.
zc:607384129701944763
0